Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,5.965890632850744e-54,333.8860398860399,40918.91503193749,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.3386291280774916e-51,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.7660032981604496e-36,50.26293183940243,4115.310713973133,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.421366464394481e-34,0,0,59
3,Nonalcoholic fatty liver disease WP4396,3.0242143558445498e-22,12.39106753812636,613.9801312871348,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CYC1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",3.951640091636878e-20,0,0,50
4,Oxidative phosphorylation WP623,5.989749644101458e-21,36.46232876712329,1697.8405305816614,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",5.869954651219429e-19,0,0,35
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.1435928014750527e-15,27.924070716228467,960.7165254753507,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",8.965767563564414e-14,0,0,27
6,Mitochondrial CIV Assembly WP4922,2.5515307155647882e-11,36.94694244604317,901.2003086429834,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",1.6670000675023282e-09,0,0,18
7,mRNA Processing WP411,2.6010738533046755e-06,7.666479820627803,98.58775793299598,"['SF3B5', 'SF3A1', 'NCBP2', 'SNU13', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SNRPB', 'SRSF9']",0.00014566013578506184,0,0,15
8,Mitochondrial complex III assembly WP4921,1.7430758874824245e-05,32.55614973262032,356.72665824528355,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.000854107184866388,0,0,8
9,Pyrimidine metabolism WP4022,0.00019590838915709677,3.84412292744746,32.82059648679504,"['NME2', 'NME1', 'POLE4', 'POLD4', 'ZNRD1', 'POLD2', 'POLE3', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.008532898727731327,0,0,16
10,Computational Model of Aerobic Glycolysis WP4629,0.0002933918694908497,14.227515583259127,115.72663172946466,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.010863131221142287,0,0,7
11,Cellular Proteostasis WP4918,0.0003048327638585846,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.010863131221142287,0,0,5
12,Eukaryotic Transcription Initiation WP405,0.00035090255800881867,7.325245316681534,58.27234103884525,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.011462816894954743,0,0,9
13,7q11.23 copy number variation syndrome WP4932,0.00045614065752196527,3.437966550127563,26.447277378863863,"['ATP5PB', 'CLTC', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'DNAJC30', 'CFL1', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.013754395211431568,0,0,16
14,Nucleotide Excision Repair WP4753,0.0011593770657211996,6.505525846702318,43.97652481648123,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5']",0.028364625517106622,0,0,8
15,Cholesterol Biosynthesis Pathway WP197,0.0011651238132354544,12.184163701067616,82.3031475680953,"['IDI1', 'NSDHL', 'HMGCS1', 'CYP51A1', 'PMVK', 'MSMO1']",0.028364625517106622,0,0,6
16,Cori Cycle WP1946,0.0011651238132354544,12.184163701067616,82.3031475680953,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.028364625517106622,0,0,6
17,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0012924397214728468,1.8369250625782227,12.21779930896577,"['YWHAE', 'RPL5', 'SET', 'NOTCH4', 'CLTC', 'CCDC124', 'ARPC5L', 'CRIP2', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'CFL1', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'DNAJA1', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'ARF6']",0.028364625517106622,0,0,42
18,Proteasome Degradation WP183,0.001302457294152855,3.5318412414204716,23.463796372942618,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC3', 'PSMA2', 'PSME3', 'PSME1']",0.028364625517106622,0,0,13
19,Translation Factors WP107,0.0014487614113100238,4.521825396825397,29.559381919342403,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF3G', 'EIF4B', 'EIF1']",0.02989023543334365,0,0,10
20,DNA Repair Pathways Full Network WP4946,0.0019378474283716523,3.3103737690241717,20.677182135928614,"['FEN1', 'RFC3', 'CENPX', 'RPA2', 'RAD23A', 'GTF2H5', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3']",0.03798180959608439,0,0,13
21,Base Excision Repair WP4752,0.002237347736469695,5.420083184789067,33.07586338411278,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3']",0.041763824414100974,0,0,8
22,DNA Mismatch Repair WP531,0.006056238625433324,6.0894128113879,31.09659955899288,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2']",0.1079111609622665,0,0,6
23,Ciliary landscape WP4352,0.007652948882820374,2.091938091938092,10.193311913094115,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'SNRPB2', 'COPS8', 'DCAF11', 'CALM2']",0.12718664165286886,0,0,20
24,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.007786937244053196,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.12718664165286886,0,0,3
25,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.010993634016600768,4.060552092609083,18.314872111843442,"['IDI1', 'NSDHL', 'HMGCS1', 'PMVK', 'CYP51A1', 'MSMO1', 'DHCR24']",0.17238018138030003,0,0,7
26,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.016405146869325274,8.108348134991118,33.32660946697486,"['RAB5C', 'RRAS', 'KRAS', 'HRAS']",0.2381784286213151,0,0,4
27,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.016405146869325274,8.108348134991118,33.32660946697486,"['EIF5', 'EIF3I', 'EIF3G', 'EIF1']",0.2381784286213151,0,0,4
28,Selenium Micronutrient Network WP15,0.021253850071782543,2.203036407042674,8.48437174747346,"['GPX4', 'HBA1', 'TXN', 'SELENOK', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'SELENOS', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.2936297756633739,0,0,13
29,Glycolysis and Gluconeogenesis WP534,0.021722610954688373,2.5396205357142856,9.725226895723837,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.2936297756633739,0,0,10
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.026524103743941527,12.154392191659273,44.116814161686456,"['IDI1', 'HMGCS1', 'PMVK']",0.3465816222541693,0,0,3
31,Photodynamic therapy-induced unfolded protein response WP3613,0.0315900421140994,4.0551111111111116,14.010057436555183,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'HSP90B1']",0.3838859318039248,0,0,5
32,Fatty acid transporters WP5061,0.03231692793247326,5.404381290704559,18.548723456456642,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.3838859318039248,0,0,4
33,Glycolysis in senescence WP5049,0.03231692793247326,5.404381290704559,18.548723456456642,"['LDHA', 'PKM', 'PGK1', 'GAPDH']",0.3838859318039248,0,0,4
34,Androgen receptor signaling pathway WP138,0.034147513813457785,2.4363960749330955,8.227869123057047,"['SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'FKBP4', 'RAN']",0.3910880372842773,0,0,9
35,Leptin signaling pathway WP2034,0.03591624832202547,2.8405164737310775,9.449164065010029,"['SOCS3', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.3910880372842773,0,0,7
36,Non-small cell lung cancer WP4255,0.03591624832202547,2.8405164737310775,9.449164065010029,"['GADD45B', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.3910880372842773,0,0,7
37,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.039314614045504966,inf,inf,"['ELOB', 'ELOC']",0.4007761828400725,0,0,2
38,Mevalonate pathway WP3963,0.039314614045504966,inf,inf,"['HMGCS1', 'PMVK']",0.4007761828400725,0,0,2
39,Ras signaling WP4223,0.04018463847416024,1.956961437713452,6.290203387362945,"['RAB5C', 'RASA4B', 'BAD', 'GNG10', 'GNG3', 'RRAS', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'ARF6']",0.4007761828400725,0,0,13
40,Melanoma WP4685,0.040895528861231885,2.497737556561086,7.984603920675937,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.4007761828400725,0,0,8
41,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.04900177759577655,2.5817210394236216,7.786209137054255,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.46850480042791237,0,0,7
42,Metabolic reprogramming in colon cancer WP4290,0.05345387257923063,2.318818436465495,6.791671240694829,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'PYCR2', 'GAPDH']",0.4821599123747996,0,0,8
43,Alzheimer's disease WP2059,0.05619012490858775,2.1488167077714224,6.186473924229227,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'GAPDH', 'HSD17B10', 'CALM2']",0.4821599123747996,0,0,9
44,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.05657998971745097,6.07586512866016,17.450491597107693,"['NSDHL', 'CYP51A1', 'DHCR24']",0.4821599123747996,0,0,3
45,HIF1A and PPARG regulation of glycolysis WP2456,0.05657998971745097,6.07586512866016,17.450491597107693,"['LDHA', 'TPI1', 'GAPDH']",0.4821599123747996,0,0,3
46,RalA downstream regulated genes WP2290,0.05657998971745097,6.07586512866016,17.450491597107693,"['RAC3', 'KRAS', 'HRAS']",0.4821599123747996,0,0,3
47,Ferroptosis WP4313,0.05870083582235979,2.7034400948991695,7.6650672516784875,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.48958994983755405,0,0,6
48,G13 Signaling Pathway WP524,0.07017470271524036,2.895238095238095,7.6919741666242825,"['CFL2', 'ARHGDIB', 'CFL1', 'ARHGDIG', 'CALM2']",0.5730934055077962,0,0,5
49,G Protein Signaling Pathways WP35,0.08321148753083088,2.1835742174121515,5.429173141776433,"['GNG10', 'GNG3', 'RRAS', 'PRKAR1A', 'KRAS', 'HRAS', 'CALM2']",0.6592826900809043,0,0,7
50,Cell cycle WP179,0.08409217985725821,1.785951742627346,4.421733803167598,"['YWHAE', 'CDKN2D', 'ANAPC13', 'CCNB1', 'GADD45B', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.6592826900809043,0,0,11
51,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.09606167595508214,2.5327777777777776,5.933702715019337,"['ACLY', 'IDI1', 'HMGCS1', 'CYP51A1', 'DBI']",0.7383564112625921,0,0,5
52,Cytosolic DNA-sensing pathway WP4655,0.10204249805393764,2.2109349725008087,5.04616259915093,"['POLR2E', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.743130684067762,0,0,6
53,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.10237004321341618,8.095744680851064,18.451506804848655,"['RRAS', 'IKBKG']",0.743130684067762,0,0,2
54,Peroxiredoxin 2 induced ovarian failure WP4873,0.10237004321341618,8.095744680851064,18.451506804848655,"['STAR', 'BAX']",0.743130684067762,0,0,2
55,Pancreatic adenocarcinoma pathway WP4263,0.10436947753898254,2.027159394479074,4.581011302737583,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG']",0.7438697308232938,0,0,7
56,Amyotrophic lateral sclerosis (ALS) WP2447,0.11779906006534113,2.700414446417999,5.775578872176598,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.794129619714018,0,0,4
57,Copper homeostasis WP3286,0.11779906006534113,2.700414446417999,5.775578872176598,"['COX17', 'MT3', 'ATOX1', 'SOD1']",0.794129619714018,0,0,4
58,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.11779906006534113,2.700414446417999,5.775578872176598,"['CFL1', 'BANF1', 'KRAS', 'HRAS']",0.794129619714018,0,0,4
59,DNA Replication WP466,0.1260531510099597,2.250864197530864,4.661655959724042,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'UBA52']",0.794129619714018,0,0,5
60,Genotoxicity pathway WP4286,0.1260531510099597,2.250864197530864,4.661655959724042,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1', 'PHLDA3']",0.794129619714018,0,0,5
61,Small cell lung cancer WP4658,0.12607760581646435,1.8019409784115668,3.7315632463923594,"['LAMB3', 'GADD45B', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.794129619714018,0,0,8
62,Synaptic Vesicle Pathway WP2267,0.12607760581646435,1.8019409784115668,3.7315632463923594,"['RAB3A', 'CLTC', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2']",0.794129619714018,0,0,8
63,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.12856286910846468,2.0262455516014235,4.156512958458435,"['BAD', 'STMN1', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.794129619714018,0,0,6
64,Myometrial relaxation and contraction pathways WP289,0.14366320760236057,1.4493914157591288,2.812230328538322,"['YWHAE', 'YWHAB', 'GSTO1', 'ACTG1', 'RGS4', 'CNN1', 'CREB3', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'YWHAH']",0.794129619714018,0,0,15
65,Regulation of Actin Cytoskeleton WP51,0.1445594833503825,1.6586246046549347,3.2078864801328426,"['RRAS', 'CFL2', 'TMSB4X', 'CFL1', 'BRK1', 'RAC3', 'KRAS', 'ARPC5', 'ACTG1']",0.794129619714018,0,0,9
66,GABA receptor Signaling WP4159,0.1450833568060958,3.0366015971606033,5.861997918751113,"['GABBR1', 'AP2S1', 'AP2M1']",0.794129619714018,0,0,3
67,Gastric Cancer Network 2 WP2363,0.1450833568060958,3.0366015971606033,5.861997918751113,"['RFC3', 'S100A6', 'COL9A3']",0.794129619714018,0,0,3
68,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.1450833568060958,3.0366015971606033,5.861997918751113,"['SOCS3', 'CHI3L1', 'BAX']",0.794129619714018,0,0,3
69,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.1450833568060958,3.0366015971606033,5.861997918751113,"['BAD', 'KRAS', 'HRAS']",0.794129619714018,0,0,3
70,TP53 network WP1742,0.1450833568060958,3.0366015971606033,5.861997918751113,"['SUMO1', 'GADD45A', 'BAX']",0.794129619714018,0,0,3
71,TNF-alpha signaling pathway WP231,0.1496819686604143,1.706726709822685,3.241487808698494,"['BAD', 'CDC37', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.794129619714018,0,0,8
72,Interferon type I signaling pathways WP585,0.15730767620479816,2.314133468662776,4.280109422337263,"['SOCS3', 'RPS6', 'RACK1', 'EIF4B']",0.794129619714018,0,0,4
73,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.15730767620479816,2.314133468662776,4.280109422337263,"['LDHA', 'PKM', 'PGK1', 'BAX']",0.794129619714018,0,0,4
74,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.15730767620479816,2.314133468662776,4.280109422337263,"['CREB3', 'STAR', 'CALM3', 'CALM2']",0.794129619714018,0,0,4
75,DNA damage response WP707,0.15801558759615664,1.869969887763482,3.450209623998316,"['CCNB1', 'GADD45B', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.794129619714018,0,0,6
76,Endometrial cancer WP4155,0.15801558759615664,1.869969887763482,3.450209623998316,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.794129619714018,0,0,6
77,miRNA regulation of DNA damage response WP1530,0.15801558759615664,1.869969887763482,3.450209623998316,"['CCNB1', 'GADD45B', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.794129619714018,0,0,6
78,Modulators of TCR signaling and T cell activation WP5072,0.15801558759615664,1.869969887763482,3.450209623998316,"['FIBP', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.794129619714018,0,0,6
79,EGF/EGFR signaling pathway WP437,0.16045782777316958,1.5594093406593406,2.853288893297209,"['NDUFA13', 'CFL1', 'STMN1', 'AP2S1', 'NEDD8', 'KRAS', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.7961958036339554,0,0,10
80,Cysteine and methionine catabolism WP4504,0.17821601618686617,4.046985815602837,6.980074764752669,"['AHCY', 'GOT1']",0.8288702624610651,0,0,2
81,Dual hijack model of Vif in HIV infection WP3300,0.17821601618686617,4.046985815602837,6.980074764752669,"['ELOB', 'ELOC']",0.8288702624610651,0,0,2
82,Homologous recombination WP186,0.17821601618686617,4.046985815602837,6.980074764752669,"['POLD4', 'POLD2']",0.8288702624610651,0,0,2
83,Trans-sulfuration pathway WP2333,0.17821601618686617,4.046985815602837,6.980074764752669,"['AHCY', 'GOT1']",0.8288702624610651,0,0,2
84,Amino Acid metabolism WP3925,0.19007449274757457,1.7360193187595323,2.8823809556550257,"['ACLY', 'LDHA', 'PKM', 'GOT1', 'ODC1', 'PYCR1']",0.8288702624610651,0,0,6
85,Thermogenesis WP4321,0.19007449274757457,1.7360193187595323,2.8823809556550257,"['CREB3', 'RPS6', 'ZNF516', 'KRAS', 'HRAS', 'ACTG1']",0.8288702624610651,0,0,6
86,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.19834976126369752,inf,inf,['MAP1LC3A'],0.8288702624610651,0,0,1
87,Insulin signaling in adipocytes (diabetic condition) WP3635,0.19834976126369752,inf,inf,['RPS6'],0.8288702624610651,0,0,1
88,Insulin signaling in adipocytes (normal condition) WP3634,0.19834976126369752,inf,inf,['RPS6'],0.8288702624610651,0,0,1
89,MED and Pseudoachondroplasia genes WP4789,0.19834976126369752,inf,inf,['COL9A3'],0.8288702624610651,0,0,1
90,miRNA Biogenesis WP2338,0.19834976126369752,inf,inf,['RAN'],0.8288702624610651,0,0,1
91,Mitochondrial CII Assembly WP4920,0.19834976126369752,inf,inf,['SDHAF1'],0.8288702624610651,0,0,1
92,NLR Proteins WP288,0.19834976126369752,inf,inf,['IKBKG'],0.8288702624610651,0,0,1
93,The alternative pathway of fetal androgen synthesis WP4524,0.19834976126369752,inf,inf,['STAR'],0.8288702624610651,0,0,1
94,Methionine De Novo and Salvage Pathway WP3580,0.199342078362826,2.428748890860692,3.9169233472373506,"['AHCY', 'ODC1', 'TXN']",0.8288702624610651,0,0,3
95,Parkinson's disease pathway WP2371,0.2008741707494928,2.024422735346359,3.2493535268496494,"['PINK1', 'SYT11', 'CYCS', 'PARK7']",0.8288702624610651,0,0,4
96,Hepatitis B infection WP4666,0.2188364147806838,1.4586262265834076,2.216281603789932,"['CREB3', 'YWHAQ', 'YWHAB', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.8935820270211254,0,0,9
97,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.22435650092267936,1.6199288256227757,2.4210143603963297,"['POMC', 'CREB3', 'BAD', 'RPS6', 'ZNF516', 'HRAS']",0.9066778181617557,0,0,6
98,Aryl Hydrocarbon Receptor Netpath WP2586,0.24745750320628584,1.7990921649891454,2.512461742184279,"['CDC37', 'AIP', 'KRAS', 'HRAS']",0.9589455501990728,0,0,4
99,MET in type 1 papillary renal cell carcinoma WP4205,0.24745750320628584,1.7990921649891454,2.512461742184279,"['BAD', 'RPL11', 'KRAS', 'HRAS']",0.9589455501990728,0,0,4
100,Canonical and non-canonical Notch signaling WP3845,0.25735539903854593,2.023513753327418,2.7465097007716897,"['RRAS', 'NOTCH4', 'DLL3']",0.9589455501990728,0,0,3
101,MAPK Cascade WP422,0.25735539903854593,2.023513753327418,2.7465097007716897,"['RRAS', 'KRAS', 'HRAS']",0.9589455501990728,0,0,3
102,Glycerophospholipid Biosynthetic Pathway WP2533,0.2593067049007697,2.6973995271867612,3.6407980966303723,"['PTPMT1', 'CDIPT']",0.9589455501990728,0,0,2
103,Nanoparticle-mediated activation of receptor signaling WP2643,0.2593067049007697,2.6973995271867612,3.6407980966303723,"['KRAS', 'HRAS']",0.9589455501990728,0,0,2
104,"Relationship between inflammation, COX-2 and EGFR WP4483",0.2593067049007697,2.6973995271867612,3.6407980966303723,"['KRAS', 'HRAS']",0.9589455501990728,0,0,2
105,Rett syndrome causing genes WP4312,0.2593067049007697,2.6973995271867612,3.6407980966303723,"['EIF2B2', 'IMPDH2']",0.9589455501990728,0,0,2
106,SARS-CoV-2 mitochondrial interactions WP5038,0.2593067049007697,2.6973995271867612,3.6407980966303723,"['NDUFB9', 'PHB']",0.9589455501990728,0,0,2
107,NO/cGMP/PKG mediated Neuroprotection WP4008,0.29601923967568927,1.6188277087033747,1.9706488748083932,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.999169268579966,0,0,4
108,Notch Signaling Pathway Netpath WP61,0.29601923967568927,1.6188277087033747,1.9706488748083932,"['PSENEN', 'NOTCH4', 'SKP1', 'DLL3']",0.999169268579966,0,0,4
109,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.29789040256803495,1.4287209545740005,1.7302234186212513,"['RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.999169268579966,0,0,6
110,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.31323219112259393,1.3493618284357376,1.5663534310825116,"['PSMD8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMC3', 'STUB1']",0.999169268579966,0,0,7
111,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3171652507624846,1.7340600836607936,1.991277282503964,"['H3F3B', 'H2AFZ', 'H3F3A']",0.999169268579966,0,0,3
112,Histone Modifications WP2369,0.3171652507624846,1.7340600836607936,1.991277282503964,"['SET', 'H3F3B', 'H3F3A']",0.999169268579966,0,0,3
113,IL-2 signaling pathway WP49,0.3171652507624846,1.7340600836607936,1.991277282503964,"['SOCS3', 'RPS6', 'HRAS']",0.999169268579966,0,0,3
114,Nanomaterial induced apoptosis WP2507,0.3171652507624846,1.7340600836607936,1.991277282503964,"['ENDOG', 'BAX', 'CYCS']",0.999169268579966,0,0,3
115,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3171652507624846,1.7340600836607936,1.991277282503964,"['MAP1LC3A', 'ATG101', 'FTL']",0.999169268579966,0,0,3
116,p38 MAPK Signaling Pathway WP400,0.3171652507624846,1.7340600836607936,1.991277282503964,"['DDIT3', 'HRAS', 'MEF2D']",0.999169268579966,0,0,3
117,Regulation of Microtubule Cytoskeleton WP2038,0.3171652507624846,1.7340600836607936,1.991277282503964,"['PARD6A', 'CFL2', 'STMN1']",0.999169268579966,0,0,3
118,Integrated breast cancer pathway WP1984,0.3251730658139874,1.2954010695187166,1.4552506185906111,"['RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU']",0.999169268579966,0,0,8
119,Pathways in clear cell renal cell carcinoma WP4018,0.3251730658139874,1.2954010695187166,1.4552506185906111,"['ACLY', 'LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.999169268579966,0,0,8
120,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3405826061135792,2.0226063829787235,2.1785444412613852,"['H3F3B', 'H3F3A']",0.999169268579966,0,0,2
121,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3405826061135792,2.0226063829787235,2.1785444412613852,"['CD63', 'SOD1']",0.999169268579966,0,0,2
122,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3405826061135792,2.0226063829787235,2.1785444412613852,"['BAD', 'BAX']",0.999169268579966,0,0,2
123,Serotonin and anxiety WP3947,0.3405826061135792,2.0226063829787235,2.1785444412613852,"['POMC', 'CRH']",0.999169268579966,0,0,2
124,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3405826061135792,2.0226063829787235,2.1785444412613852,"['KRAS', 'HRAS']",0.999169268579966,0,0,2
125,Tumor suppressor activity of SMARCB1 WP4204,0.3405826061135792,2.0226063829787235,2.1785444412613852,"['H3F3B', 'H3F3A']",0.999169268579966,0,0,2
126,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3455792012186986,1.471338608105926,1.5633464513736837,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.999169268579966,0,0,4
127,Cell Differentiation - Index WP2029,0.35738481184107046,4.044286979627989,4.161337434702096,['MEF2D'],0.999169268579966,0,0,1
128,Effects of nitric oxide WP1995,0.35738481184107046,4.044286979627989,4.161337434702096,['HBA1'],0.999169268579966,0,0,1
129,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.35738481184107046,4.044286979627989,4.161337434702096,['GABBR1'],0.999169268579966,0,0,1
130,Heme Biosynthesis WP561,0.35738481184107046,4.044286979627989,4.161337434702096,['UROD'],0.999169268579966,0,0,1
131,Hippo-Yap signaling pathway WP4537,0.35738481184107046,4.044286979627989,4.161337434702096,['YWHAQ'],0.999169268579966,0,0,1
132,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.35738481184107046,4.044286979627989,4.161337434702096,['AHCY'],0.999169268579966,0,0,1
133,Mitochondrial fatty acid synthesis pathway WP4317,0.35738481184107046,4.044286979627989,4.161337434702096,['MCAT'],0.999169268579966,0,0,1
134,Molybdenum cofactor (Moco) biosynthesis WP4507,0.35738481184107046,4.044286979627989,4.161337434702096,['MOCS2'],0.999169268579966,0,0,1
135,Nanoparticle triggered autophagic cell death WP2509,0.35738481184107046,4.044286979627989,4.161337434702096,['MAP1LC3A'],0.999169268579966,0,0,1
136,Purine metabolism WP4792,0.35738481184107046,4.044286979627989,4.161337434702096,['APRT'],0.999169268579966,0,0,1
137,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.35738481184107046,4.044286979627989,4.161337434702096,['MAS1'],0.999169268579966,0,0,1
138,TCA cycle in senescence WP5050,0.35738481184107046,4.044286979627989,4.161337434702096,['GOT1'],0.999169268579966,0,0,1
139,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.37696577820795707,1.171605286675133,1.143019136553362,"['YWHAE', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ATP1A3', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.999169268579966,0,0,11
140,ATM Signaling Pathway WP2516,0.377111825608841,1.5169698314108253,1.4793694827511963,"['CCNB1', 'GADD45A', 'IKBKG']",0.999169268579966,0,0,3
141,CAMKK2  Pathway WP4874,0.377111825608841,1.5169698314108253,1.4793694827511963,"['FIS1', 'MAP1LC3A', 'CALM2']",0.999169268579966,0,0,3
142,Endothelin Pathways WP2197,0.377111825608841,1.5169698314108253,1.4793694827511963,"['CNN1', 'RIIAD1', 'CALM2']",0.999169268579966,0,0,3
143,miRNA regulation of prostate cancer signaling pathways WP3981,0.377111825608841,1.5169698314108253,1.4793694827511963,"['BAD', 'KRAS', 'IKBKG']",0.999169268579966,0,0,3
144,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.377111825608841,1.5169698314108253,1.4793694827511963,"['RPS6', 'PIM2', 'EIF4B']",0.999169268579966,0,0,3
145,Urea cycle and metabolism of amino groups WP497,0.377111825608841,1.5169698314108253,1.4793694827511963,"['GAMT', 'ODC1', 'PYCR1']",0.999169268579966,0,0,3
146,IL-18 signaling pathway WP4754,0.3822469879257038,1.1092188078489449,1.0667227652419933,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'SOCS3', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'RPS11', 'RAE1', 'AARS', 'ITM2C', 'ARF6']",0.999169268579966,0,0,20
147,Acute viral myocarditis WP4298,0.39525255385560853,1.3484310242747188,1.2516545902132954,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.999169268579966,0,0,4
148,IL-3 signaling pathway WP286,0.39525255385560853,1.3484310242747188,1.2516545902132954,"['YWHAQ', 'YWHAB', 'BAD', 'HRAS']",0.999169268579966,0,0,4
149,PPAR signaling pathway WP3942,0.39525255385560853,1.3484310242747188,1.2516545902132954,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.999169268579966,0,0,4
150,DNA damage response (only ATM dependent) WP710,0.4064169494780434,1.2641666666666667,1.1382249185870033,"['BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.999169268579966,0,0,5
151,G1 to S cell cycle control WP45,0.4064169494780434,1.2641666666666667,1.1382249185870033,"['CDKN2D', 'CREB3', 'CCNB1', 'GADD45A', 'RPA2']",0.999169268579966,0,0,5
152,Biomarkers for urea cycle disorders WP4583,0.41878227790937433,1.6177304964539008,1.4080792846963524,"['GAMT', 'GOT1']",0.999169268579966,0,0,2
153,Lipid Metabolism Pathway WP3965,0.41878227790937433,1.6177304964539008,1.4080792846963524,"['ACLY', 'PRKAR1A']",0.999169268579966,0,0,2
154,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.41878227790937433,1.6177304964539008,1.4080792846963524,"['YWHAQ', 'ACTG1']",0.999169268579966,0,0,2
155,Nucleotide metabolism WP404,0.41878227790937433,1.6177304964539008,1.4080792846963524,"['NME2', 'OAZ1']",0.999169268579966,0,0,2
156,22q11.2 copy number variation syndrome WP4657,0.4197173792134445,1.1799124369249034,1.0243689470353805,"['RANBP1', 'CYP26B1', 'MRPL40', 'THAP7', 'DGCR6L', 'EMC10', 'RAN']",0.999169268579966,0,0,7
157,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.43585768856866786,1.3481218574386276,1.11953362947396,"['STAR', 'KRAS', 'HRAS']",0.999169268579966,0,0,3
158,Kit receptor signaling pathway WP304,0.43585768856866786,1.3481218574386276,1.11953362947396,"['BAD', 'RPS6', 'HRAS']",0.999169268579966,0,0,3
159,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4442714690277619,1.2444322994944665,1.009632174408692,"['BEX3', 'SOCS3', 'SERBP1', 'RNF7']",0.999169268579966,0,0,4
160,Sleep regulation WP3591,0.4442714690277619,1.2444322994944665,1.009632174408692,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.999169268579966,0,0,4
161,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4442714690277619,1.2444322994944665,1.009632174408692,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.999169268579966,0,0,4
162,Pathogenic Escherichia coli infection WP2272,0.4493509186049522,1.1895424836601307,0.9515758665754188,"['TUBA1A', 'YWHAQ', 'ARPC5L', 'ARPC5', 'ACTG1']",0.999169268579966,0,0,5
163,Exercise-induced Circadian Regulation WP410,0.4527569174541481,1.15556685307575,0.9156710629634126,"['DNAJA1', 'IDI1', 'HSPA8', 'SUMO1', 'GSTP1', 'STBD1']",0.999169268579966,0,0,6
164,Adipogenesis WP236,0.45700477871153006,1.11574159444342,0.8736942100658202,"['SOCS3', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'CISD1', 'HMGA1', 'MEF2D']",0.999169268579966,0,0,8
165,Canonical NF-KB pathway WP4562,0.48489211317838,2.021700620017715,1.4633652547344551,['IKBKG'],0.999169268579966,0,0,1
166,Gastric acid production WP2596,0.48489211317838,2.021700620017715,1.4633652547344551,['CCK'],0.999169268579966,0,0,1
167,Glycerolipids and Glycerophospholipids WP4722,0.48489211317838,2.021700620017715,1.4633652547344551,['CDIPT'],0.999169268579966,0,0,1
168,Iron metabolism in placenta WP2007,0.48489211317838,2.021700620017715,1.4633652547344551,['FTH1'],0.999169268579966,0,0,1
169,PPAR-alpha pathway WP2878,0.48489211317838,2.021700620017715,1.4633652547344551,['DBI'],0.999169268579966,0,0,1
170,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.48489211317838,2.021700620017715,1.4633652547344551,['IKBKG'],0.999169268579966,0,0,1
171,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.48489211317838,2.021700620017715,1.4633652547344551,['DLL3'],0.999169268579966,0,0,1
172,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.48489211317838,2.021700620017715,1.4633652547344551,['HMGCS1'],0.999169268579966,0,0,1
173,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.48489211317838,2.021700620017715,1.4633652547344551,['MEF2D'],0.999169268579966,0,0,1
174,Statin inhibition of cholesterol production WP430,0.48489211317838,2.021700620017715,1.4633652547344551,['APOC1'],0.999169268579966,0,0,1
175,Supression of HMGB1 mediated inflammation by THBD WP4479,0.48489211317838,2.021700620017715,1.4633652547344551,['IKBKG'],0.999169268579966,0,0,1
176,Valproic acid pathway WP3871,0.48489211317838,2.021700620017715,1.4633652547344551,['HSD17B10'],0.999169268579966,0,0,1
177,Vitamin D in inflammatory diseases WP4482,0.48489211317838,2.021700620017715,1.4633652547344551,['IKBKG'],0.999169268579966,0,0,1
178,Senescence and Autophagy in Cancer WP615,0.48959713019527556,1.0783125371360665,0.7701010626577025,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'SPARC', 'MAP1LC3A', 'HMGA1', 'HRAS', 'GABARAP']",0.999169268579966,0,0,8
179,Insulin Signaling WP481,0.4901955872519178,1.0886704568806083,0.7761684839066414,"['CAP1', 'SOCS3', 'XBP1', 'HRAS', 'PFKM', 'VAMP2', 'ARF6']",0.999169268579966,0,0,7
180,Retinoblastoma gene in cancer WP2446,0.4914232652306472,1.12320987654321,0.7979838673566224,"['RFC3', 'CCNB1', 'H2AFZ', 'STMN1', 'RPA2']",0.999169268579966,0,0,5
181,Autophagy WP4923,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['MAP1LC3B', 'ATG101']",0.999169268579966,0,0,2
182,BDNF-TrkB Signaling WP3676,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['KRAS', 'HRAS']",0.999169268579966,0,0,2
183,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['KRAS', 'HRAS']",0.999169268579966,0,0,2
184,Galanin receptor pathway WP4970,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['POMC', 'VAMP2']",0.999169268579966,0,0,2
185,Glycosylation and related congenital defects WP4521,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['DPM2', 'DPM3']",0.999169268579966,0,0,2
186,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['LDHA', 'RPS6']",0.999169268579966,0,0,2
187,Imatinib and Chronic Myeloid Leukemia WP3640,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['GADD45A', 'PIM2']",0.999169268579966,0,0,2
188,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['GOT1', 'HMGA1']",0.999169268579966,0,0,2
189,Unfolded protein response WP4925,0.4919289742812618,1.3478132387706856,0.9561669268785961,"['XBP1', 'DDIT3']",0.999169268579966,0,0,2
190,DNA IR-damage and cellular response via ATR WP4016,0.4923777169020066,1.2130434782608697,0.8594523912661993,"['FEN1', 'RPA2', 'IKBKG']",0.999169268579966,0,0,3
191,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4923777169020066,1.2130434782608697,0.8594523912661993,"['ARHGDIB', 'CYCS', 'ACTG1']",0.999169268579966,0,0,3
192,16p11.2 proximal deletion syndrome WP4949,0.5279486945003729,1.0546185981742224,0.6736441360574525,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.999169268579966,0,0,6
193,Folate Metabolism WP176,0.5379076992432612,1.0780343398460628,0.66845491644377,"['AHCY', 'GPX4', 'HBA1', 'SOD1']",0.999169268579966,0,0,4
194,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5379076992432612,1.0780343398460628,0.66845491644377,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.999169268579966,0,0,4
195,Aryl Hydrocarbon Receptor Pathway WP2873,0.5459299973785389,1.1025248043881584,0.6673191480444605,"['CDC37', 'AIP', 'BAX']",0.999169268579966,0,0,3
196,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5459299973785389,1.1025248043881584,0.6673191480444605,"['IFI27L2', 'KRAS', 'HRAS']",0.999169268579966,0,0,3
197,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5459299973785389,1.1025248043881584,0.6673191480444605,"['TKFC', 'PIN1', 'IKBKG']",0.999169268579966,0,0,3
198,Oxidative Damage WP3941,0.5459299973785389,1.1025248043881584,0.6673191480444605,"['BAD', 'GADD45A', 'CYCS']",0.999169268579966,0,0,3
199,Breast cancer pathway WP4262,0.5529240317775882,1.0104723707664884,0.5987399042891332,"['GADD45B', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.999169268579966,0,0,8
200,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5589499527262445,1.155015197568389,0.6718669578719954,"['MAP1LC3A', 'EIF2B2']",0.999169268579966,0,0,2
201,PDGF Pathway WP2526,0.5589499527262445,1.155015197568389,0.6718669578719954,"['ARFIP2', 'HRAS']",0.999169268579966,0,0,2
202,Fragile X Syndrome  WP4549,0.563926310631009,1.0104537366548043,0.5788199225742386,"['DUSP3', 'PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.999169268579966,0,0,6
203,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5816172875685025,1.0104351687388988,0.5475978918305953,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.999169268579966,0,0,4
204,ACE Inhibitor Pathway WP554,0.5871173983232904,1.34750516681429,0.717587575990817,['MAS1'],0.999169268579966,0,0,1
205,Alanine and aspartate metabolism WP106,0.5871173983232904,1.34750516681429,0.717587575990817,['GOT1'],0.999169268579966,0,0,1
206,Cannabinoid receptor signaling WP3869,0.5871173983232904,1.34750516681429,0.717587575990817,['PRKAR1A'],0.999169268579966,0,0,1
207,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5871173983232904,1.34750516681429,0.717587575990817,['STAR'],0.999169268579966,0,0,1
208,Dopamine metabolism WP2436,0.5871173983232904,1.34750516681429,0.717587575990817,['SOD1'],0.999169268579966,0,0,1
209,Genes targeted by miRNAs in adipocytes WP1992,0.5871173983232904,1.34750516681429,0.717587575990817,['TMSB4X'],0.999169268579966,0,0,1
210,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5871173983232904,1.34750516681429,0.717587575990817,['VEGFB'],0.999169268579966,0,0,1
211,Nanoparticle triggered regulated necrosis WP2513,0.5871173983232904,1.34750516681429,0.717587575990817,['FTL'],0.999169268579966,0,0,1
212,Purine metabolism and related disorders WP4224,0.5871173983232904,1.34750516681429,0.717587575990817,['APRT'],0.999169268579966,0,0,1
213,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5871173983232904,1.34750516681429,0.717587575990817,['BAX'],0.999169268579966,0,0,1
214,Serotonin and anxiety-related events WP3944,0.5871173983232904,1.34750516681429,0.717587575990817,['CRH'],0.999169268579966,0,0,1
215,Sulfation Biotransformation Reaction WP692,0.5871173983232904,1.34750516681429,0.717587575990817,['SULT4A1'],0.999169268579966,0,0,1
216,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5871173983232904,1.34750516681429,0.717587575990817,['ACLY'],0.999169268579966,0,0,1
217,IL-6 signaling pathway WP364,0.5960176613790452,1.0104259094942325,0.5228802307269702,"['SOCS3', 'BAD', 'NR2F6']",0.999169268579966,0,0,3
218,Interleukin-11 Signaling Pathway WP2332,0.5960176613790452,1.0104259094942325,0.5228802307269702,"['SOCS3', 'RPS6', 'HRAS']",0.999169268579966,0,0,3
219,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6161095558000819,0.9502587390431936,0.4602392720956652,"['LAMB3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'RAB14', 'CDC37', 'KRAS', 'IKBKG', 'PELO', 'HRAS', 'EIF4B']",0.999169268579966,0,0,16
220,Alpha 6 Beta 4 signaling pathway WP244,0.6193960806410436,1.0104166666666667,0.4840000301659489,"['LAMB3', 'HRAS']",0.999169268579966,0,0,2
221,Integrated Cancer Pathway WP1971,0.6193960806410436,1.0104166666666667,0.4840000301659489,"['BAD', 'BAX']",0.999169268579966,0,0,2
222,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6193960806410436,1.0104166666666667,0.4840000301659489,"['RAB3A', 'NEFL']",0.999169268579966,0,0,2
223,Notch Signaling WP268,0.6193960806410436,1.0104166666666667,0.4840000301659489,"['NOTCH4', 'DLL3']",0.999169268579966,0,0,2
224,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6212726223474925,0.9426832888097358,0.4487033767101438,"['RAB3A', 'BAD', 'CFL1', 'RPS6', 'RACK1', 'IKBKG', 'HRAS']",0.999169268579966,0,0,7
225,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6212726223474925,0.9426832888097358,0.4487033767101438,"['SPARC', 'NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'MEF2D', 'DLL3']",0.999169268579966,0,0,7
226,Oncostatin M Signaling Pathway WP2374,0.6228408660832695,0.9507888412914011,0.45016450137766273,"['SOCS3', 'RPS6', 'KRAS', 'HRAS']",0.999169268579966,0,0,4
227,Prolactin Signaling Pathway WP2037,0.6228408660832695,0.9507888412914011,0.45016450137766273,"['SOCS3', 'RPS6', 'PPIB', 'HRAS']",0.999169268579966,0,0,4
228,Calcium Regulation in the Cardiac Cell WP536,0.6251899212675692,0.9393687707641196,0.4412213250485901,"['RGS4', 'YWHAE', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ANXA6', 'CALM3', 'CALM2', 'YWHAH']",0.999169268579966,0,0,10
229,Apoptosis WP254,0.6613941552363499,0.8977698835602921,0.3711428418976316,"['BAD', 'CYCS', 'BAX', 'IKBKG']",0.999169268579966,0,0,4
230,Cancer immunotherapy by CTLA4 blockade WP4582,0.6690699912548599,1.0104074402125776,0.4060490062670379,['HLA-DRB1'],0.999169268579966,0,0,1
231,Cell Differentiation - Index expanded WP2023,0.6690699912548599,1.0104074402125776,0.4060490062670379,['MEF2D'],0.999169268579966,0,0,1
232,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6690699912548599,1.0104074402125776,0.4060490062670379,['CCK'],0.999169268579966,0,0,1
233,Ebstein-Barr virus LMP1 signaling WP262,0.6690699912548599,1.0104074402125776,0.4060490062670379,['IKBKG'],0.999169268579966,0,0,1
234,EPO Receptor Signaling WP581,0.6690699912548599,1.0104074402125776,0.4060490062670379,['EPOR'],0.999169268579966,0,0,1
235,Ethanol effects on histone modifications WP3996,0.6690699912548599,1.0104074402125776,0.4060490062670379,['AHCY'],0.999169268579966,0,0,1
236,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6690699912548599,1.0104074402125776,0.4060490062670379,['RPS6'],0.999169268579966,0,0,1
237,Glutathione metabolism WP100,0.6690699912548599,1.0104074402125776,0.4060490062670379,['GPX4'],0.999169268579966,0,0,1
238,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6690699912548599,1.0104074402125776,0.4060490062670379,['IKBKG'],0.999169268579966,0,0,1
239,IL17 signaling pathway WP2112,0.6690699912548599,1.0104074402125776,0.4060490062670379,['IKBKG'],0.999169268579966,0,0,1
240,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6690699912548599,1.0104074402125776,0.4060490062670379,['SUPT4H1'],0.999169268579966,0,0,1
241,Intraflagellar transport proteins binding to dynein WP4532,0.6690699912548599,1.0104074402125776,0.4060490062670379,['DYNLL1'],0.999169268579966,0,0,1
242,Leptin Insulin Overlap WP3935,0.6690699912548599,1.0104074402125776,0.4060490062670379,['SOCS3'],0.999169268579966,0,0,1
243,NOTCH1 regulation of endothelial cell calcification WP3413,0.6690699912548599,1.0104074402125776,0.4060490062670379,['DLL3'],0.999169268579966,0,0,1
244,Osteoclast Signaling WP12,0.6690699912548599,1.0104074402125776,0.4060490062670379,['ATP6V1G1'],0.999169268579966,0,0,1
245,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6690699912548599,1.0104074402125776,0.4060490062670379,['ANAPC11'],0.999169268579966,0,0,1
246,Resistin as a regulator of inflammation WP4481,0.6690699912548599,1.0104074402125776,0.4060490062670379,['IKBKG'],0.999169268579966,0,0,1
247,Role of Osx and miRNAs in tooth development WP3971,0.6690699912548599,1.0104074402125776,0.4060490062670379,['NOTCH4'],0.999169268579966,0,0,1
248,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6690699912548599,1.0104074402125776,0.4060490062670379,['IDH3B'],0.999169268579966,0,0,1
249,TLR4 Signaling and Tolerance WP3851,0.6690699912548599,1.0104074402125776,0.4060490062670379,['IKBKG'],0.999169268579966,0,0,1
250,Trans-sulfuration and one-carbon metabolism WP2525,0.6690699912548599,1.0104074402125776,0.4060490062670379,['AHCY'],0.999169268579966,0,0,1
251,AGE/RAGE pathway WP2324,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['CYCS', 'SOD1']",0.999169268579966,0,0,2
252,One-carbon metabolism and related pathways WP3940,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['GPX4', 'SOD1']",0.999169268579966,0,0,2
253,Oxidation by Cytochrome P450 WP43,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['CYP26B1', 'CYP51A1']",0.999169268579966,0,0,2
254,Oxidative Stress WP408,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['TXN2', 'SOD1']",0.999169268579966,0,0,2
255,Pre-implantation embryo WP3527,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['DDIT3', 'HMGA1']",0.999169268579966,0,0,2
256,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['KRAS', 'HRAS']",0.999169268579966,0,0,2
257,Type 2 papillary renal cell carcinoma WP4241,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['ELOB', 'ELOC']",0.999169268579966,0,0,2
258,Type II interferon signaling (IFNG) WP619,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['SOCS3', 'HLA-B']",0.999169268579966,0,0,2
259,Urea cycle and associated pathways WP4595,0.6732369752222148,0.8979511426319937,0.35528145765063146,"['GOT1', 'PYCR1']",0.999169268579966,0,0,2
260,Gastrin signaling pathway WP4659,0.6779597343350688,0.8780676328502416,0.34127624780809757,"['BAD', 'RPS6', 'KRAS', 'HRAS', 'MEF2D']",0.999169268579966,0,0,5
261,ErbB signaling pathway WP673,0.6847929704845838,0.8656990746609202,0.3277871889034329,"['BAD', 'KRAS', 'HRAS']",0.999169268579966,0,0,3
262,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6847929704845838,0.8656990746609202,0.3277871889034329,"['NDUFA13', 'COPS6', 'IKBKG']",0.999169268579966,0,0,3
263,Chemokine signaling pathway WP3929,0.7092120041220878,0.8412962962962963,0.2890700624737265,"['GNG10', 'GNG3', 'KRAS', 'IKBKG', 'HRAS']",0.999169268579966,0,0,5
264,Common Pathways Underlying Drug Addiction WP2636,0.7207127789763829,0.8079787234042554,0.2646248169870577,"['CALM2', 'ACTG1']",0.999169268579966,0,0,2
265,Joubert Syndrome WP4656,0.7207127789763829,0.8079787234042554,0.2646248169870577,"['PDE6G', 'ARL2']",0.999169268579966,0,0,2
266,Airway smooth muscle cell contraction WP4962,0.7347673874269862,0.80814880425155,0.24907251978219372,['CALM2'],0.999169268579966,0,0,1
267,Apoptosis Modulation by HSP70 WP384,0.7347673874269862,0.80814880425155,0.24907251978219372,['CYCS'],0.999169268579966,0,0,1
268,Cytokines and Inflammatory Response WP530,0.7347673874269862,0.80814880425155,0.24907251978219372,['HLA-DRB1'],0.999169268579966,0,0,1
269,Energy Metabolism WP1541,0.7347673874269862,0.80814880425155,0.24907251978219372,['MEF2D'],0.999169268579966,0,0,1
270,ERK Pathway in Huntington's Disease WP3853,0.7347673874269862,0.80814880425155,0.24907251978219372,['HRAS'],0.999169268579966,0,0,1
271,Fatty acid beta-oxidation WP143,0.7347673874269862,0.80814880425155,0.24907251978219372,['TPI1'],0.999169268579966,0,0,1
272,Fatty Acid Biosynthesis WP357,0.7347673874269862,0.80814880425155,0.24907251978219372,['ACLY'],0.999169268579966,0,0,1
273,Hedgehog Signaling Pathway Netpath WP47,0.7347673874269862,0.80814880425155,0.24907251978219372,['SAP18'],0.999169268579966,0,0,1
274,IL-7 signaling pathway WP205,0.7347673874269862,0.80814880425155,0.24907251978219372,['BAD'],0.999169268579966,0,0,1
275,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7347673874269862,0.80814880425155,0.24907251978219372,['SPARC'],0.999169268579966,0,0,1
276,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7347673874269862,0.80814880425155,0.24907251978219372,['BAX'],0.999169268579966,0,0,1
277,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7347673874269862,0.80814880425155,0.24907251978219372,['YWHAQ'],0.999169268579966,0,0,1
278,Overview of nanoparticle effects WP3287,0.7347673874269862,0.80814880425155,0.24907251978219372,['BAX'],0.999169268579966,0,0,1
279,PDGFR-beta pathway WP3972,0.7347673874269862,0.80814880425155,0.24907251978219372,['HRAS'],0.999169268579966,0,0,1
280,Phosphoinositides metabolism WP4971,0.7347673874269862,0.80814880425155,0.24907251978219372,['PIP4P1'],0.999169268579966,0,0,1
281,Physiological and pathological hypertrophy of the heart WP1528,0.7347673874269862,0.80814880425155,0.24907251978219372,['CALM2'],0.999169268579966,0,0,1
282,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7347673874269862,0.80814880425155,0.24907251978219372,['LDHA'],0.999169268579966,0,0,1
283,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7347673874269862,0.80814880425155,0.24907251978219372,['CDC37'],0.999169268579966,0,0,1
284,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7347673874269862,0.80814880425155,0.24907251978219372,['IKBKG'],0.999169268579966,0,0,1
285,Ebola Virus Pathway on Host WP4217,0.7382691114973042,0.8074666666666667,0.24502323353763092,"['SOCS3', 'CLTC', 'HLA-B', 'HLA-DRB1', 'ACTG1']",0.999169268579966,0,0,5
286,Head and Neck Squamous Cell Carcinoma WP4674,0.7581234692532814,0.7571539485359361,0.20966275667257459,"['RPS6', 'KRAS', 'HRAS']",0.999169268579966,0,0,3
287,Bladder cancer WP2828,0.7622281893431841,0.7343649258542876,0.19938691213664214,"['KRAS', 'HRAS']",0.999169268579966,0,0,2
288,IL-5 signaling pathway WP127,0.7622281893431841,0.7343649258542876,0.19938691213664214,"['RPS6', 'KRAS']",0.999169268579966,0,0,2
289,PI3K-Akt signaling pathway WP4172,0.7841447249696999,0.8281835493580687,0.2013825011333839,"['LAMB3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'CDC37', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS', 'EIF4B']",0.999169268579966,0,0,15
290,Cancer immunotherapy by PD-1 blockade WP4585,0.7874314910022878,0.6733097136108651,0.16090681984820973,['HLA-DRB1'],0.999169268579966,0,0,1
291,Estrogen signaling pathway WP712,0.7874314910022878,0.6733097136108651,0.16090681984820973,['IKBKG'],0.999169268579966,0,0,1
292,Gastric Cancer Network 1 WP2361,0.7874314910022878,0.6733097136108651,0.16090681984820973,['H3F3A'],0.999169268579966,0,0,1
293,Genes related to primary cilium development (based on CRISPR) WP4536,0.7874314910022878,0.6733097136108651,0.16090681984820973,['DYNLL1'],0.999169268579966,0,0,1
294,Heart Development WP1591,0.7874314910022878,0.6733097136108651,0.16090681984820973,['VEGFB'],0.999169268579966,0,0,1
295,MAPK pathway in congenital thyroid cancer WP4928,0.7874314910022878,0.6733097136108651,0.16090681984820973,['KRAS'],0.999169268579966,0,0,1
296,miRNAs involvement in the immune response in sepsis WP4329,0.7874314910022878,0.6733097136108651,0.16090681984820973,['IKBKG'],0.999169268579966,0,0,1
297,MTHFR deficiency WP4288,0.7874314910022878,0.6733097136108651,0.16090681984820973,['CYCS'],0.999169268579966,0,0,1
298,Neovascularisation processes WP4331,0.7874314910022878,0.6733097136108651,0.16090681984820973,['NOTCH4'],0.999169268579966,0,0,1
299,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7874314910022878,0.6733097136108651,0.16090681984820973,['OMG'],0.999169268579966,0,0,1
300,One-carbon metabolism WP241,0.7874314910022878,0.6733097136108651,0.16090681984820973,['AHCY'],0.999169268579966,0,0,1
301,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.7874314910022878,0.6733097136108651,0.16090681984820973,['HLA-DRB1'],0.999169268579966,0,0,1
302,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7874314910022878,0.6733097136108651,0.16090681984820973,['BAX'],0.999169268579966,0,0,1
303,Splicing factor NOVA regulated synaptic proteins WP4148,0.7874314910022878,0.6733097136108651,0.16090681984820973,['APLP2'],0.999169268579966,0,0,1
304,Toll-like Receptor Signaling related to MyD88 WP3858,0.7874314910022878,0.6733097136108651,0.16090681984820973,['IKBKG'],0.999169268579966,0,0,1
305,Transcriptional cascade regulating adipogenesis WP4211,0.7874314910022878,0.6733097136108651,0.16090681984820973,['DDIT3'],0.999169268579966,0,0,1
306,Hippo-Merlin Signaling Dysregulation WP4541,0.7892715740144925,0.7124588966021191,0.16859970526893678,"['PRKAR1A', 'KRAS', 'HRAS']",0.999169268579966,0,0,3
307,p53 transcriptional gene network WP4963,0.7892715740144925,0.7124588966021191,0.16859970526893678,"['SIVA1', 'GADD45A', 'BAX']",0.999169268579966,0,0,3
308,Cardiac Hypertrophic Response WP2795,0.7982778312696667,0.6730200945626478,0.1516304733931902,"['IKBKG', 'CALM2']",0.999169268579966,0,0,2
309,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7982778312696667,0.6730200945626478,0.1516304733931902,"['NABP2', 'BAX']",0.999169268579966,0,0,2
310,Proximal tubule transport WP4917,0.8128259565223971,0.7018302571627153,0.14544608690333388,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.999169268579966,0,0,4
311,Circadian rhythm related genes WP3594,0.8132741732134973,0.7752403846153846,0.16023210151466913,"['AHCY', 'STAR', 'CAVIN3', 'CRH', 'OPRL1', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.999169268579966,0,0,10
312,Glioblastoma signaling pathways WP2261,0.8293947229600468,0.6211129296235679,0.1161848216814452,"['KRAS', 'HRAS']",0.999169268579966,0,0,2
313,IL-4 signaling pathway WP395,0.8293947229600468,0.6211129296235679,0.1161848216814452,"['SOCS3', 'BAD']",0.999169268579966,0,0,2
314,MECP2 and Associated Rett Syndrome WP3584,0.8293947229600468,0.6211129296235679,0.1161848216814452,"['GAMT', 'RPS6']",0.999169268579966,0,0,2
315,Tryptophan metabolism WP465,0.8293947229600468,0.6211129296235679,0.1161848216814452,"['DHCR24', 'HSD17B10']",0.999169268579966,0,0,2
316,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8296460547903363,0.5769960774389472,0.10775754241992716,['GSTP1'],0.999169268579966,0,0,1
317,Striated Muscle Contraction Pathway WP383,0.8296460547903363,0.5769960774389472,0.10775754241992716,['ACTG1'],0.999169268579966,0,0,1
318,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8296460547903363,0.5769960774389472,0.10775754241992716,['CALM2'],0.999169268579966,0,0,1
319,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8296460547903363,0.5769960774389472,0.10775754241992716,['PPIB'],0.999169268579966,0,0,1
320,TGF-beta Signaling Pathway WP366,0.8331669514773982,0.6954789272030651,0.1269396726785839,"['PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'SKP1']",0.999169268579966,0,0,5
321,Focal Adhesion WP306,0.8348857623763538,0.7237025367034272,0.13059963117364443,"['LAMB3', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.999169268579966,0,0,7
322,Endoderm differentiation WP2853,0.8415808528565156,0.6371830196609536,0.10989698683017977,"['TCEAL2', 'NABP2', 'NME1']",0.999169268579966,0,0,3
323,Integrin-mediated Cell Adhesion WP185,0.856115620693749,0.5766210739614995,0.08957799219045984,"['RAC3', 'HRAS']",0.999169268579966,0,0,2
324,Vitamin B12 metabolism WP1533,0.856115620693749,0.5766210739614995,0.08957799219045984,"['HBA1', 'SOD1']",0.999169268579966,0,0,2
325,Ectoderm Differentiation WP2858,0.8632413141585431,0.6051907719609583,0.08899996287144447,"['ARHGDIG', 'CELSR2', 'LY6E']",0.999169268579966,0,0,3
326,Cardiac Progenitor Differentiation WP2406,0.8634829864289526,0.5047608503100088,0.07408934508468351,['MESP1'],0.999169268579966,0,0,1
327,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8634829864289526,0.5047608503100088,0.07408934508468351,['IKBKG'],0.999169268579966,0,0,1
328,Melatonin metabolism and effects WP3298,0.8634829864289526,0.5047608503100088,0.07408934508468351,['CALM2'],0.999169268579966,0,0,1
329,Pathways affected in adenoid cystic carcinoma WP3651,0.8634829864289526,0.5047608503100088,0.07408934508468351,['HRAS'],0.999169268579966,0,0,1
330,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8634829864289526,0.5047608503100088,0.07408934508468351,['HRAS'],0.999169268579966,0,0,1
331,3q29 copy number variation syndrome WP4906,0.8789585828151351,0.5380614657210402,0.06941934565602753,"['NCBP2', 'DYNLL1']",0.999169268579966,0,0,2
332,Metapathway biotransformation Phase I and II WP702,0.8812695403867971,0.6535539097816678,0.0826038234307791,"['CYP26B1', 'GPX4', 'GSTO1', 'GSTP1', 'CYP51A1', 'SULT4A1']",0.999169268579966,0,0,6
333,B Cell Receptor Signaling Pathway WP23,0.8822526082645853,0.5762454049942959,0.07219021495766638,"['IKBKG', 'HRAS', 'MEF2D']",0.999169268579966,0,0,3
334,Corticotropin-releasing hormone signaling pathway WP2355,0.8822526082645853,0.5762454049942959,0.07219021495766638,"['POMC', 'STAR', 'CRH']",0.999169268579966,0,0,3
335,Male infertility WP4673,0.8822526082645853,0.5762454049942959,0.07219021495766638,"['PIWIL1', 'CYP26B1', 'HMGA1']",0.999169268579966,0,0,3
336,7-oxo-C and 7beta-HC pathways WP5064,0.8906036734839571,0.44857789587639013,0.051970333662168806,['ACOT4'],0.999169268579966,0,0,1
337,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8906036734839571,0.44857789587639013,0.051970333662168806,['DDIT3'],0.999169268579966,0,0,1
338,Microglia Pathogen Phagocytosis Pathway WP3937,0.8906036734839571,0.44857789587639013,0.051970333662168806,['RAC3'],0.999169268579966,0,0,1
339,Pregnane X receptor pathway WP2876,0.8906036734839571,0.44857789587639013,0.051970333662168806,['PSMC5'],0.999169268579966,0,0,1
340,Prion disease pathway WP3995,0.8906036734839571,0.44857789587639013,0.051970333662168806,['HSP90B1'],0.999169268579966,0,0,1
341,Target Of Rapamycin (TOR) Signaling WP1471,0.8906036734839571,0.44857789587639013,0.051970333662168806,['IDI1'],0.999169268579966,0,0,1
342,White fat cell differentiation WP4149,0.8906036734839571,0.44857789587639013,0.051970333662168806,['DDIT3'],0.999169268579966,0,0,1
343,MAPK Signaling Pathway WP382,0.8922938803254663,0.6941194581280788,0.07910167187677086,"['HSPA8', 'DUSP3', 'RRAS', 'GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.999169268579966,0,0,10
344,Glycogen Synthesis and Degradation WP500,0.898409273693623,0.5043218085106383,0.054027769992632535,"['CALM3', 'CALM2']",0.999169268579966,0,0,2
345,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.898409273693623,0.5043218085106383,0.054027769992632535,"['IKBKG', 'CALM2']",0.999169268579966,0,0,2
346,Prader-Willi and Angelman Syndrome WP3998,0.898409273693623,0.5043218085106383,0.054027769992632535,"['POMC', 'FEZ1']",0.999169268579966,0,0,2
347,Prostaglandin Synthesis and Regulation WP98,0.898409273693623,0.5043218085106383,0.054027769992632535,"['ANXA6', 'S100A6']",0.999169268579966,0,0,2
348,Mesodermal commitment pathway WP2857,0.8988720593917009,0.5499314350246027,0.058630702922870696,"['PRKAR1A', 'NABP2', 'RPL38']",0.999169268579966,0,0,3
349,Blood Clotting Cascade WP272,0.912340264393784,0.4036315323294951,0.037030069616124456,['F8A1'],0.999169268579966,0,0,1
350,Nuclear receptors WP170,0.912340264393784,0.4036315323294951,0.037030069616124456,['NR2F6'],0.999169268579966,0,0,1
351,RANKL/RANK signaling pathway WP2018,0.912340264393784,0.4036315323294951,0.037030069616124456,['IKBKG'],0.999169268579966,0,0,1
352,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.912340264393784,0.4036315323294951,0.037030069616124456,['RPS6'],0.999169268579966,0,0,1
353,Vitamin D-sensitive calcium signaling in depression WP4698,0.912340264393784,0.4036315323294951,0.037030069616124456,['GPX4'],0.999169268579966,0,0,1
354,Neural Crest Differentiation WP2064,0.9149134290169464,0.47455152273675427,0.04219988864405766,"['NOTCH4', 'DLL3']",0.999169268579966,0,0,2
355,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9149134290169464,0.47455152273675427,0.04219988864405766,"['SOCS3', 'STMN1']",0.999169268579966,0,0,2
356,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9288735790137537,0.44808904649330183,0.033061189354369386,"['CAP1', 'HRAS']",0.999169268579966,0,0,2
357,ATM Signaling Network in Development and Disease  WP3878,0.9297608676634908,0.3668572348820356,0.026717426404088106,['IKBKG'],0.999169268579966,0,0,1
358,IL-1 signaling pathway WP195,0.9297608676634908,0.3668572348820356,0.026717426404088106,['IKBKG'],0.999169268579966,0,0,1
359,Oxysterols derived from cholesterol WP4545,0.9297608676634908,0.3668572348820356,0.026717426404088106,['ACOT4'],0.999169268579966,0,0,1
360,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9297608676634908,0.3668572348820356,0.026717426404088106,['BAX'],0.999169268579966,0,0,1
361,Zinc homeostasis WP3529,0.9297608676634908,0.3668572348820356,0.026717426404088106,['MT3'],0.999169268579966,0,0,1
362,Apoptosis Modulation and Signaling WP1772,0.9372487807302998,0.5197960236062568,0.03368617361836089,"['ENDOG', 'BAD', 'CYCS', 'BAX']",0.999169268579966,0,0,4
363,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9505553646115102,0.4031028368794326,0.020440889701981945,"['HMGCS1', 'CALM2']",0.999169268579966,0,0,2
364,Endochondral Ossification WP474,0.9505553646115102,0.4031028368794326,0.020440889701981945,"['HMGCS1', 'CALM2']",0.999169268579966,0,0,2
365,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9549097777108123,0.31028139265517474,0.014315892146867227,['HRAS'],0.999169268579966,0,0,1
366,TGF-beta Receptor Signaling WP560,0.9549097777108123,0.31028139265517474,0.014315892146867227,['HRAS'],0.999169268579966,0,0,1
367,Allograft Rejection WP2328,0.958870935915628,0.383823032759203,0.016120104907414765,"['HLA-B', 'HLA-DRB1']",0.999169268579966,0,0,2
368,Peptide GPCRs WP24,0.958870935915628,0.383823032759203,0.016120104907414765,"['OPRL1', 'HCRTR1']",0.999169268579966,0,0,2
369,T-cell receptor (TCR) signaling pathway WP69,0.958870935915628,0.383823032759203,0.016120104907414765,"['IKBKG', 'HRAS']",0.999169268579966,0,0,2
370,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9638750685780468,0.2880551689231937,0.010598583690775225,['RAE1'],0.999169268579966,0,0,1
371,Vitamin A and carotenoid metabolism WP716,0.9638750685780468,0.2880551689231937,0.010598583690775225,['CYP26B1'],0.999169268579966,0,0,1
372,Complement system WP2806,0.9654314765301352,0.45998477543770616,0.016182334150243147,"['FKBP2', 'RPS19', 'CD59', 'TXN']",0.999169268579966,0,0,4
373,Monoamine GPCRs WP58,0.9710589641240703,0.26879244168881017,0.007893919914865872,['HTR5A'],0.999169268579966,0,0,1
374,Osteoblast differentiation WP4787,0.9716591054645557,0.35029293863706445,0.010071009761892475,"['NOTCH4', 'DLL3']",0.999169268579966,0,0,2
375,Ciliopathies WP4803,0.9764970577265816,0.3895011019835704,0.009263715720993432,"['NEK2', 'CCNQ', 'CCDC28B']",0.999169268579966,0,0,3
376,Phosphodiesterases in neuronal function WP4222,0.9768151730278097,0.25193755535872453,0.0059099065563533865,['PDE6G'],0.999169268579966,0,0,1
377,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9768151730278097,0.25193755535872453,0.0059099065563533865,['YWHAQ'],0.999169268579966,0,0,1
378,Toll-like Receptor Signaling Pathway WP75,0.9814272224533575,0.2370655968321784,0.004444367676898601,['IKBKG'],0.999169268579966,0,0,1
379,Spinal Cord Injury WP2431,0.9814438433032331,0.41244250125244797,0.007725246878749096,"['BCAN', 'GADD45A', 'APEX1', 'OMG']",0.999169268579966,0,0,4
380,NRF2 pathway WP2884,0.9833149784599067,0.43681159420289856,0.007349697735245911,"['FTH1', 'PRDX1', 'GSTP1', 'TXN', 'FTL']",0.999169268579966,0,0,5
381,AMP-activated protein kinase (AMPK) signaling WP1403,0.9851223734675122,0.22384607814191518,0.0033553203072814153,['CCNB1'],0.999169268579966,0,0,1
382,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9851223734675122,0.22384607814191518,0.0033553203072814153,['ACTG1'],0.999169268579966,0,0,1
383,Pathways Regulating Hippo Signaling WP4540,0.9851223734675122,0.22384607814191518,0.0033553203072814153,['PRKAR1A'],0.999169268579966,0,0,1
384,Wnt signaling pathway and pluripotency WP399,0.9880827790704757,0.21201808773483755,0.00254184250529778,['PPM1J'],0.999169268579966,0,0,1
385,Nuclear Receptors Meta-Pathway WP2882,0.9888951900817605,0.5246287076045789,0.005858491332779335,"['PSMC5', 'GADD45B', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'FTL']",0.999169268579966,0,0,11
386,Regulation of toll-like receptor signaling pathway WP1449,0.9890529314233908,0.2874240121580547,0.0031637993051467387,"['CUEDC2', 'IKBKG']",0.999169268579966,0,0,2
387,Glucocorticoid Receptor Pathway WP2880,0.9904544311862808,0.20137289636846767,0.0019314519796351062,['GADD45B'],0.999169268579966,0,0,1
388,ESC Pluripotency Pathways WP3931,0.9938762562452077,0.1829857476447379,0.0011240029055702883,['HRAS'],0.999169268579966,0,0,1
389,Complement and Coagulation Cascades WP558,0.9960718044811493,0.16766312370829642,0.0006599105102273697,['CLTC'],0.999169268579966,0,0,1
390,Vitamin D Receptor Pathway WP2877,0.9969777291346754,0.3209236234458259,0.0009713867545949042,"['CDKN2D', 'GADD45A', 'S100A6', 'HLA-DRB1']",0.999169268579966,0,0,4
391,"GPCRs, Class A Rhodopsin-like WP455",0.9982160302112141,0.358527646465183,0.0006401736849287325,"['MAS1', 'GPR22', 'APLNR', 'OPRL1', 'HTR5A', 'HCRTR1']",0.999169268579966,0,0,6
392,"GPCRs, Other WP117",0.999169268579966,0.1296037029629418,0.00010771061369656539,['CELSR2'],0.999169268579966,0,0,1
